Quantcast

New Impotency Drug Proves Faster Than Rivals

January 12, 2010

Biotech firm Vivus revealed a new medication for erectile dysfunction on Monday that may be hitting pharmacy shelves in the near future.

The new drug, called avanafil, is said to be effective in just 15 minutes, far faster than big market rivals Cialis and Viagra, according to AFP.

Leland Wilson, CEO for Vivus, shined the spotlight on optimistic results for the class three investigational drug to treat male impotency. “The magnitude of success in the first 15 minutes was surprising,” he said.

Data shows promising results that avanafil will work better than the “currently available oral ED therapies,” Wilson said, referring to erectile dysfunction. While “we knew from the pharmacokinetic profile that avanafil works very quickly, this data is exciting evidence of how fast avanafil really works,” he emphasized.

Dr Charles Bowden, who works with Vivus, said that knowing avanafil can act in 15 minutes and last the length of a sexual encounter is a huge plus in such a highly beneficial market.

Vivus is planning a potential market launch for early 2012. The drug is in its final phase of review by the Food and Drug Administration.

Pfizer says its drug, Viagra, acts within 30 minutes to one hour after it is taken. Cialis, made by Eli Lilly, starts working from 30 minutes to as much as six hours after it is taken. Levitra maker acts within 25 to 60 minutes of ingestion.

According to a recent report by the American College of Physicians, it is believed that nearly 322 million men worldwide will have ED by 2020.

On the Net:




comments powered by Disqus